ReShape Lifesciences Inc reports results for the quarter ended in September - Earnings Summary

Vyome Holdings

15/11/2022 02:37

* ReShape Lifesciences Inc  RSLS.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 35 cents per share.
    * Revenue fell 24.5% to $2.80 million from a year ago;
analysts
expected $3.62 million. 
    * ReShape Lifesciences Inc's reported EPS for the quarter
was a
loss of 52 cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ReShape Lifesciences Inc shares had fallen by 22.5% this
quarter and lost 85.8% so far this year.
    * The company reported a quarterly loss of $11.81 million.
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $1.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 02:37 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.35          -0.22          Beat
 Jun. 30 2022      -0.36          -0.50          Missed
 Mar. 31 2022      -0.34          -0.44          Missed
 Dec. 31 2021      -0.17          -0.54          Missed